Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets ... Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. 더 보기
WESTPORT, Conn., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2 | 4.88997555012 | 4.09 | 5 | 3.81 | 44658 | 4.61222872 | CS |
4 | -1.52 | -26.1617900172 | 5.81 | 6.1932 | 3.8 | 35686 | 4.75665445 | CS |
12 | 0.59 | 15.9459459459 | 3.7 | 23.01 | 2.81 | 948200 | 9.58904179 | CS |
26 | -0.894 | -17.2453703704 | 5.184 | 23.01 | 2.098 | 1314927 | 6.60713544 | CS |
52 | -24.71 | -85.2068965517 | 29 | 40.8 | 2.098 | 725042 | 6.79889908 | CS |
156 | -316.71 | -98.6635514019 | 321 | 333.6 | 2.098 | 260720 | 14.4213708 | CS |
260 | -745.71 | -99.428 | 750 | 899.526 | 2.098 | 215020 | 30.2178162 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관